Azitra

Azitra is a biotechnology startup that combines the function of the microbiome with the latest molecular genetics to develop biotherapies for treating skin diseases, including cancer-related rashes, Netherton syndrome, atopic dermatitis, and ichthyosis vulgaris.Azitra aims to treat malnutrition and dysbiosis-related diseases, improve skin barrier function, accelerate wound healing and tissue repair, and address skin inflammation. The company’s key products and their functions include: Filaggrin (restores the skin barrier), LEKTI (restores missing protease inhibitors and treats Netherton syndrome), and IL-10 (suppresses inflammation).